1)De Palma GD, Masone S, Rega M, et al. Metastatic tumors to the stomach:clinical and endoscopic features. World J Gastroenterol 12:7326-7328, 2006
2)Kobayashi O, Murakami H, Yoshida T, et al. Clinical diagnosis of metastatic gastric tumors:clinicopathologic findings and prognosis of nine patients in a cancer center. World J Surg 28:548-551, 2004
3)Xu L, Liang S, Yan N, et al. Metastatic gastric cancer from breast carcinoma:a report of 78 cases. Oncol Lett 14:4069-4077, 2017
4)Oda I, Kondo H, Yamao T, et al. Metastatic tumors to the stomach:analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy 33:507-510, 2001
5)Arpino G, Bardou VJ, Clark GM, et al. Infiltrating lobular carcinoma of the breast:tumor characteristics and clinical outcome. Breast Cancer Res 6:R149-156, 2004
6)Ferlicot S, Vincent-Salomon A, Médioni J, et al. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 40:336-341, 2004
7)Almubarak MM, LaéM, Cacheux W, et al. Gastric metastasis of breast cancer:a single centre retrospective study. Dig Liver Dis 43:823-827, 2011
8)Yoshida Y. Metastases and primary neoplasms of the stomach in patients with breast cancer. Am J Surg 125:738-743, 1973
9)Kudo T, Matsumoto T, Nakamura S, et al. Solitary minute metastasis from breast cancer mimicking primary intramucosal gastric signet-cell cancer. Gastrointest Endosc 62:139-140, 2005
10)Sangoi AR, Shrestha B, Yang G, et al. The novel marker GATA3 is significantly more sensitive than traditional markers mammaglobin and GCDFP15 for identifying breast cancer in surgical and cytology specimens of metastatic and matched primary tumors. Appl Immunohistochem Mol Morphol 24:229-237, 2016
11)Wick MR, Lillemoe TJ, Copland GT, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer:immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 20:281-287, 1989
12)Benfiguig A, Anciaux ML, Eugène CI, et al. Gastric metastasis of breast cancer occurring after a cancer-free interval of 30 years. Ann Gastroenterol Hepatol(Paris) 28:175-177, 1992
13)D'Amato A, Pezzoli F, Balducci G, et al. Critical analysis of the long-term management of a case of cancer of the breast. Chir Ital 58:377-381, 2006